ArticlePLOS global public health2025
Socioeconomic inequalities, substance use, and chronic multimorbidity in Kiambu and Nakuru counties in Kenya.
Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multimorbidity, defined as the coexistence of two or more chronic conditions in an individual, is a growing public health concern associated with increased healthcare costs, poorer quality of life, and increased mortality. Substance use, defined as the consumption of alcohol, tobacco, or other psychoactive substances, may influence the development of multimorbidity, but evidence from sub-Saharan Africa remains limited. We examined the prevalence of multimorbidity and its association with substance use, as well as socioeconomic and demographic factors, in two counties in central Kenya. Data were obtained from a household-based, cross-sectional survey using a stratified, two-stage random sampling design. To account for the complex survey design, we employed sample-weighted multivariable analysis using a modified Poisson regression model to estimate adjusted prevalence ratios (aPR) and 95% confidence intervals (CIs) for the associations. Among the 1,484 participants (median age, 36 years), 58% were female, 61% were married, and 52% reported lifetime substance use. Multimorbidity was prevalent in 7.7% of study participants and relatively higher among participants aged 36-45 years (aPR, 4.32 [95% CI, 1.15-16.28], P = 0.031) and 46 years or older (aPR, 12.52; 95% CI, 3.68-42.56; P < 0.001), female (aPR, 1.62 [95%CI, 1.16-2.27]; P = 0.005), those that were divorced or separated (aPR, 2.22 [95%CI, 1.37-3.62]; P = 0.002) and alcohol users (aPR, 1.68 [95%CI, 1.07-2.64]; P = 0.024). Multimorbidity prevalence did not vary significantly by levels of education or income. These findings underscore the need for integrated, community-based approaches to prevent and manage multimorbidity, particularly among older adults, women, and individuals with a history of alcohol use.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.